Neuropeptide FF-sensitive confinement of mu opioid receptor does not involve lipid rafts in SH-SY5Y cells.

[1]  André Lopez,et al.  Membrane partitioning of various delta-opioid receptor forms before and after agonist activations: the effect of cholesterol. , 2008, Biochimica et biophysica acta.

[2]  W. Xu,et al.  Brain region-specific N-glycosylation and lipid rafts association of the rat mu opioid receptor. , 2008, Biochemical and biophysical research communications.

[3]  W. Xu,et al.  Agonist treatment did not affect association of mu opioid receptors with lipid rafts and cholesterol reduction had opposite effects on the receptor-mediated signaling in rat brain and CHO cells , 2007, Brain Research.

[4]  P. Joshi,et al.  Lipid raft heterogeneity: an enigma , 2007, Journal of neurochemistry.

[5]  F. Dumas,et al.  Functional membrane diffusion of G-protein coupled receptors , 2007, European Biophysics Journal.

[6]  S. Mazères,et al.  Physical Association between Neuropeptide FF and μ-Opioid Receptors as a Possible Molecular Basis for Anti-opioid Activity* , 2007, Journal of Biological Chemistry.

[7]  W. Xu,et al.  Cholesterol reduction by methyl-beta-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cells. , 2007, Biochemical pharmacology.

[8]  Deborah A. Brown,et al.  Lipid rafts, detergent-resistant membranes, and raft targeting signals. , 2006, Physiology.

[9]  L. Salomé,et al.  Diffusion of the mu opioid receptor at the surface of human neuroblastoma SH‐SY5Y cells is restricted to permeable domains , 2006, FEBS letters.

[10]  Pascual Ferrara,et al.  The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Insel,et al.  Protection of adult rat cardiac myocytes from ischemic cell death: role of caveolar microdomains and delta-opioid receptors. , 2006, American journal of physiology. Heart and circulatory physiology.

[12]  S. Hinuma,et al.  Recent advances in mammalian RFamide peptides: The discovery and functional analyses of PrRP, RFRPs and QRFP , 2006, Peptides.

[13]  P. Insel,et al.  Compartmentation of G-protein-coupled receptors and their signalling components in lipid rafts and caveolae. , 2005, Biochemical Society transactions.

[14]  P. Insel,et al.  G-protein-coupled Receptor Signaling Components Localize in Both Sarcolemmal and Intracellular Caveolin-3-associated Microdomains in Adult Cardiac Myocytes* , 2005, Journal of Biological Chemistry.

[15]  B. Monsarrat,et al.  Long-Term Morphine Treatment Enhances Proteasome-Dependent Degradation of Gβ in Human Neuroblastoma SH-SY5Y Cells: Correlation with Onset of Adenylate Cyclase Sensitization , 2005, Molecular Pharmacology.

[16]  F. Goñi,et al.  Detergent-resistant membranes should not be identified with membrane rafts. , 2005, Trends in biochemical sciences.

[17]  Xianlin Han,et al.  Epidermal Growth Factor Receptors Are Localized to Lipid Rafts That Contain a Balance of Inner and Outer Leaflet Lipids , 2005, Journal of Biological Chemistry.

[18]  Akihiro Kusumi,et al.  Rapid hop diffusion of a G-protein-coupled receptor in the plasma membrane as revealed by single-molecule techniques. , 2005, Biophysical journal.

[19]  A. Finazzi-Agro’,et al.  Lipid Rafts Control Signaling of Type-1 Cannabinoid Receptors in Neuronal Cells , 2005, Journal of Biological Chemistry.

[20]  C. Mollereau,et al.  Opioid-modulating peptides: mechanisms of action. , 2005, Current topics in medicinal chemistry.

[21]  C. Mollereau,et al.  Neuropeptide FF (NPFF) Analogs Functionally Antagonize Opioid Activities in NPFF2 Receptor-Transfected SH-SY5Y Neuroblastoma Cells , 2005, Molecular Pharmacology.

[22]  D. Dean,et al.  Interprotein interactions are responsible for the confined diffusion of a G-protein-coupled receptor at the cell surface. , 2003, Biochemical Society transactions.

[23]  S. Maekawa,et al.  Molecular characterization of the detergent-insoluble cholesterol-rich membrane microdomain (raft) of the central nervous system. , 2003, Biochimica et biophysica acta.

[24]  W. G. Wood,et al.  Lipid rafts of purified mouse brain synaptosomes prepared with or without detergent reveal different lipid and protein domains , 2003, Brain Research.

[25]  J. Zajac.  Neuropeptide FF: new molecular insights. , 2001, Trends in pharmacological sciences.

[26]  J. Masson,et al.  Role of Sterols in Modulating the Human μ-Opioid Receptor Function in Saccharomyces cerevisiae * , 2000, The Journal of Biological Chemistry.

[27]  M. Hayashi,et al.  Absence of TrkB and Insulin receptor β in the Triton insoluble low‐density fraction (raft) , 2000 .

[28]  J. Zajac,et al.  Neuropeptide FF, pain and analgesia. , 1998, European journal of pharmacology.

[29]  M. Lisanti,et al.  Co-purification and Direct Interaction of Ras with Caveolin, an Integral Membrane Protein of Caveolae Microdomains , 1996, The Journal of Biological Chemistry.

[30]  A. Aarnisalo,et al.  Neuropeptide FF, a mammalian neuropeptide with multiple functions , 1996, Progress in Neurobiology.

[31]  Richard G. W. Anderson,et al.  Lipid rafts: at a crossroad between cell biology and physics , 2007, Nature Cell Biology.

[32]  John M. Walker,et al.  Lipid Rafts , 2007, Methods in Molecular Biology.

[33]  H. Loh,et al.  Chronic opioid agonist-induced adenylyl cyclase superactivation is dependent on receptor localized within lipid rafts and is independent on receptor internalization , 2006 .